I'm sure this will be interesting because they are stimulating the good side.
gitaljournal.com/pr/1980763
Nexstim has launched a multicenter double-blinded, randomized, and
sham-controlled trial to determine the therapeutic effects of navigated
rTMS (repetitive transcranial magnetic stimulation) for stroke
rehabilitation. This cutting-edge stroke therapy combines occupational
therapy with nTMS (navigated transcranial magnetic stimulation). Called
the NICHE trial (Navigated Inhibitory rTMS in Contralesional Hemisphere
Evaluation), this two year study will be conducted at twelve of the top
rehabilitation sites in the United States.
“The trial results are showing great potential for non-invasive brain
modulation and the difference Nexstim is providing is the proven
Navigation to enable this approach.” - Janne Huhtala, CEO, Nexstim
Dr. Richard Harvey, Medical Director, Center for Stroke Rehabilitation,
Rehabilitation Institute of Chicago (RIC), developed the protocol with
Nexstim and ran the single center trial. Dr. Harvey and his team at RIC
presented the trial results at the American Heart Association’s
International Stroke Conference in February, ‘The
Contrastim Stroke Study: Improving Hand and Arm Function After Stroke
with Combined Non-Invasive Brain Stimulation and Task-Oriented Therapy’
(presentation #152).
Dr. Harvey’s study approached stroke rehabilitation through a new
combination of therapies which produced significantly greater gains in
patients’ motor function 6 months post stroke. The combination of
non-invasive navigated transcranial magnetic stimulation (nTMS) along
with occupational therapy opened the door to improving the quality of
life for stroke survivors. The study showed over 80% of the active group
received a clinically meaningful response rate.
Researchers working at the following trial sites, will enroll up to 200
patients, and will look to replicate the initial findings.
Arizona
Mayo Clinic
California
Ranchos Los Amigos National Rehabilitation Institute
Georgia
Shepherd
Center
Illinois
Rehabilitation
Institute of Chicago
Indiana
Indiana University
Massachusetts
Spaulding
Rehabilitation Hospital
New York
Columbia University
Burke
Rehabilitation Center
North Carolina
Duke
University
Ohio
Ohio State University
University of Cincinnati
Texas
TIRR Memorial Hermann Hospital
About the Technology:
The NBS System uses stereotactic MRI-guided transcranial magnetic
stimulation (TMS) to non-invasively modulate precise areas of the motor
cortex. The system’s e-field based targeting tool allows the therapist
to accurately locate the patients exact stimulation target using
technology similar to mapping the globe with a GPS. The nTMS is used to
stimulate the patient’s non-injured brain hemisphere at a low frequency.
This results in down-regulation of the excitability of the healthy side
and restoration of the balance between the lesioned and healthy sides,
allowing the lesioned side to regain function. Adding navigation to TMS
is the key to finding the exact location and orientation of the e-field
of the motor area that should be inhibited by stimulation. The
stimulation is then accurately repeated in every session, assuring the
dose is applied to the correct place.
About Nexstim:
Founded in 2000, Nexstim is committed to improving the quality of life
of patients with significant unmet clinical needs. The advanced
technology providing navigation to TMS has led to Nexstim being the
world leader in image-guided transcranial magnetic stimulation (TMS).
Nexstim has pioneered the technology for brain diagnostics and with
FDA-clearance of the Navigated Brain Stimulation (NBS) System for
non-invasive pre-surgical mapping. NBS is recognized as the emerging
standard for pre-operative direct functional mapping. Nexstim’s NBS
System enables treatment of brain injury and disease using rTMS with
accurate and repeatable 3D-guidance of therapeutic electrical field.
Nexstim’s non-invasive Navigated Brain Stimulation System is not
approved by the Food and Drug Administration for therapy in commercial
use in the United States and is available to select physician for
investigational use only.
Nexstim
Jaime Bloom
+1-404-358-7440
j.bloom@nexstim.com
or
Janne
Huhtala, CEO
+358 40 8615046
janne.huhtala@nexstim.com
Use the labels in the right column to find what you want. Or you can go thru them one by one, there are only 29,112 posts. Searching is done in the search box in upper left corner. I blog on anything to do with stroke.DO NOT DO ANYTHING SUGGESTED HERE AS I AM NOT MEDICALLY TRAINED, YOUR DOCTOR IS, LISTEN TO THEM. BUT I BET THEY DON'T KNOW HOW TO GET YOU 100% RECOVERED. I DON'T EITHER, BUT HAVE PLENTY OF QUESTIONS FOR YOUR DOCTOR TO ANSWER.
Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.
What this blog is for:
My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.
Wednesday, June 11, 2014
Nexstim Initiates Multicenter Clinical Trial on the Therapeutic Effects of Navigated TMS for Stroke Rehabilitation
Labels:
contralesional,
Nexstim,
NICHE trial,
RIC,
rTMS,
stroke rehab
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment